{
  "id": "xenopus_ectopic_eye_induction_v1",
  "metadata": {
    "author": "Pai et al.",
    "description": "Induces complete, functional eye formation in non-neural tissue by establishing a hyperpolarized eye-field prepattern.",
    "version": "1.2",
    "references": [
      "Pai et al., 2012, Development 139:313-323",
      "DOI: 10.1242/dev.073759"
    ]
  },
  "developmental_context": {
    "stage_start": "NF Stage 3 (4-cell)",
    "stage_end": "NF Stage 24 (Optic Vesicle)",
    "reference_system": "Nieuwkoop and Faber"
  },
  "target_morphology": {
    "organ": "eye",
    "species": "Xenopus laevis",
    "action": "induce"
  },
  "bioelectric_state": {
    "target_vmem_range": [
      -50,
      -30
    ],
    "spatial_domain": "ventral_ectoderm",
    "duration_hours": 24,
    "notes": "Requires establishing a hyperpolarized domain mimicking the natural Anterior Neural Field."
  },
  "control_loop": {
    "monitoring_frequency": "Every 6 hours from Stage 10.5 to Stage 24",
    "feedback_mechanism": {
      "if_vmem_drifts_above": -25,
      "if_vmem_drifts_below": -55,
      "corrective_action": "If drift above -25mV: Apply booster injection of 0.5 ng Kv1.5 mRNA. If drift below -55mV: Allow endogenous depolarization for 2 hours."
    },
    "termination_criteria": {
      "anatomical_marker": "Formation of optic cup (Stage 24) with visible lens placode",
      "bioelectric_marker": "Hyperpolarized domain normalizes to -40mV",
      "max_duration_hours": 48
    }
  },
  "delivery_method": {
    "type": "microinjection",
    "spatial_restriction": "local",
    "timing": "4-cell stage (NF Stage 3), target ventral blastomere V1",
    "notes": "Single-cell microinjection ensures spatial specificity."
  },
  "hardware_drivers": [
    {
      "type": "ion_channel_mRNA",
      "name": "Kv1.5",
      "mechanism_of_action": "Voltage-gated Potassium efflux (Hyperpolarization)",
      "dosage": "1-2 ng per blastomere (initial), 0.5 ng (booster if needed)"
    },
    {
      "type": "ion_channel_mRNA",
      "name": "Kir4.1",
      "mechanism_of_action": "Inward-rectifier Potassium channel (Hyperpolarization)",
      "dosage": "1-2 ng per blastomere"
    }
  ]
}